Thorac Cardiovasc Surg 2022; 70(07): 596-600
DOI: 10.1055/s-0042-1750026
Short Communication

Perioperative Clinical Features of Mediastinal Parathyroid Adenoma: A Case Series

Fuqiang Wang
1   Department of Thoracic Surgery, Sichuan University West China Hospital, Chengdu, Sichuan, China
,
Hanlu Zhang
1   Department of Thoracic Surgery, Sichuan University West China Hospital, Chengdu, Sichuan, China
,
Guanghao Qiu
1   Department of Thoracic Surgery, Sichuan University West China Hospital, Chengdu, Sichuan, China
,
1   Department of Thoracic Surgery, Sichuan University West China Hospital, Chengdu, Sichuan, China
› Institutsangaben
Funding This study was supported by the 1·3·5 project for disciplines of Excellence-Clinical Research Incubation Project, West China Hospital, Sichuan University (No. 2021HXFH056), the grants from the Key Research Project of Sichuan Province (No. 2020YFS0249), and grants from National Key Research Project of China (No. 2017YFC0113502).

Abstract

Rare ectopic mediastinal parathyroid adenoma can result in persistent or recurrent hyperparathyroidism. In this article, we summarized the perioperative outcomes of six patients with mediastinal parathyroid adenoma. All patients underwent minimally invasive surgery (MIS). Abnormal accumulation of sestamibi was observed in four of five patients for preoperative localization of adenoma. Postoperatively, the blood calcium dropped quickly. In addition, we found adenoma function was negatively related to adenoma volume in these patients. In conclusion, although MIS is feasible for parathyroid adenoma, blood calcium should be monitored in a timely manner to avoid hypocalcemia postoperatively. In addition, sestamibi might be a potential pitfall when locating parathyroid adenoma.

These authors contributed equally to this work.




Publikationsverlauf

Eingereicht: 14. Januar 2022

Angenommen: 04. April 2022

Artikel online veröffentlicht:
28. Juli 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Bilezikian JP, Bandeira L, Khan A, Cusano NE. Hyperparathyroidism. Lancet 2018; 391 (10116): 168-178
  • 2 Roy M, Mazeh H, Chen H, Sippel RS. Incidence and localization of ectopic parathyroid adenomas in previously unexplored patients. World J Surg 2013; 37 (01) 102-106
  • 3 Phitayakorn R, McHenry CR. Incidence and location of ectopic abnormal parathyroid glands. Am J Surg 2006; 191 (03) 418-423
  • 4 Petranović Ovčariček P, Giovanella L, Carrió Gasset I. et al. The EANM practice guidelines for parathyroid imaging. Eur J Nucl Med Mol Imaging 2021; 48 (09) 2801-2822
  • 5 Wilhelm SM, Wang TS, Ruan DT. et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg 2016; 151 (10) 959-968
  • 6 Hamidi S, Aslani A, Nakhjavani M, Pajouhi M, Hedayat A, Kamalian N. Are biochemical values predictive of adenoma's weight in primary hyperparathyroidism?. ANZ J Surg 2006; 76 (10) 882-885
  • 7 Spanheimer PM, Stoltze AJ, Howe JR, Sugg SL, Lal G, Weigel RJ. Do giant parathyroid adenomas represent a distinct clinical entity?. Surgery 2013; 154 (04) 714-718 , discussion 718–719
  • 8 Fiorelli A, Vicidomini G, Laperuta P. et al. The role of Tc-99m-2-methoxy-isobutyl-isonitrile single photon emission computed tomography in visualizing anterior mediastinal tumor and differentiating histologic type of thymoma. Eur J Cardiothorac Surg 2011; 40 (01) 136-142
  • 9 Isaacs KE, Belete S, Miller BJ. et al. Video-assisted thoracoscopic surgery for ectopic mediastinal parathyroid adenoma. BJS Open 2019; 3 (06) 743-749
  • 10 Filser B, Uslar V, Weyhe D, Tabriz N. Predictors of adenoma size and location in primary hyperparathyroidism. Langenbecks Arch Surg 2021; 406 (05) 1607-1614